- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Mutual Funds
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Fund Details
Risk | Very High | - |
Rating | 1.0 | - |
Min SIP Amount | ₹200 | - |
Expense Ratio | 2.45 | - |
NAV | ₹27.35 | - |
Fund Started | 08 Feb 2019 | - |
Fund Size | ₹84.18 Cr | - |
Exit Load | Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days. | - |
Risk
Very High
-
Rating
1.0
-
Min SIP Amount
₹200
-
Expense Ratio
2.45
-
NAV
₹27.35
-
Fund Started
08 Feb 2019
-
Fund Size
₹84.18 Cr
-
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
-
Returns
1 Year | 16.44% | - |
3 Year | 17.36% | - |
5 Year | 16.69% | - |
1 Year
16.44%
-
3 Year
17.36%
-
5 Year
16.69%
-
Holding Analysis
Equity | 95.82% | - |
Cash | 4.18% | - |
Equity
95.82%
-
Cash
4.18%
-
Top Holdings
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.09% |
Piramal Pharma Ltd. | 5.27% |
Torrent Pharmaceuticals Ltd. | 5.18% |
Cipla Ltd. | 5.02% |
Aurobindo Pharma Ltd. | 4.57% |
Divi's Laboratories Ltd. | 4.45% |
Artemis Medicare Services Ltd. | 4.12% |
Alkem Laboratories Ltd. | 3.78% |
Navin Fluorine International Ltd. | 3.56% |
Apollo Hospitals Enterprise Ltd. | 3.53% |
-
Fund Manager
Name | Karan Doshi | - |
Start Date | 31 Jul 2023 | - |
Name
Karan Doshi
-
Start Date
31 Jul 2023
-
About Fund
Description | The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. | - |
Launch Date | 08 Feb 2019 | - |
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
-
Launch Date
08 Feb 2019
-